Your browser doesn't support javascript.
loading
The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel.
Monks, Anne; Zhao, Yingdong; Hose, Curtis; Hamed, Hossein; Krushkal, Julia; Fang, Jianwen; Sonkin, Dmitriy; Palmisano, Alida; Polley, Eric C; Fogli, Laura K; Konaté, Mariam M; Miller, Sarah B; Simpson, Melanie A; Voth, Andrea Regier; Li, Ming-Chung; Harris, Erik; Wu, Xiaolin; Connelly, John W; Rapisarda, Annamaria; Teicher, Beverly A; Simon, Richard; Doroshow, James H.
Afiliación
  • Monks A; Molecular Pharmacology Group, Frederick National Laboratory for Cancer Research sponsored by the NCI, Frederick, Maryland.
  • Zhao Y; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland.
  • Hose C; Molecular Pharmacology Group, Frederick National Laboratory for Cancer Research sponsored by the NCI, Frederick, Maryland.
  • Hamed H; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland.
  • Krushkal J; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland.
  • Fang J; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland.
  • Sonkin D; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland.
  • Palmisano A; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland.
  • Polley EC; Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland.
  • Fogli LK; Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland.
  • Konaté MM; Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland.
  • Miller SB; Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland.
  • Simpson MA; Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the NCI, Frederick, Maryland.
  • Voth AR; Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the NCI, Frederick, Maryland.
  • Li MC; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland.
  • Harris E; Molecular Pharmacology Group, Frederick National Laboratory for Cancer Research sponsored by the NCI, Frederick, Maryland.
  • Wu X; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research sponsored by the NCI, Frederick, Maryland.
  • Connelly JW; Molecular Pharmacology Group, Frederick National Laboratory for Cancer Research sponsored by the NCI, Frederick, Maryland.
  • Rapisarda A; Molecular Pharmacology Group, Frederick National Laboratory for Cancer Research sponsored by the NCI, Frederick, Maryland.
  • Teicher BA; Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland.
  • Simon R; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland.
  • Doroshow JH; Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland. doroshoj@mail.nih.gov.
Cancer Res ; 78(24): 6807-6817, 2018 12 15.
Article en En | MEDLINE | ID: mdl-30355619
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos de Selección de Medicamentos Antitumorales / Perfilación de la Expresión Génica / National Cancer Institute (U.S.) / Investigación Biomédica Traslacional Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Cancer Res Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos de Selección de Medicamentos Antitumorales / Perfilación de la Expresión Génica / National Cancer Institute (U.S.) / Investigación Biomédica Traslacional Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Cancer Res Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos